{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:54:14Z","timestamp":1770566054301,"version":"3.49.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JRR"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1269\/jrr.09134","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T02:30:23Z","timestamp":1277865023000},"page":"481-484","source":"Crossref","is-referenced-by-count":19,"title":["Concurrent Chemoradiotherapy with S-1 for T2N0 Glottic Squamous Cell Carcinoma"],"prefix":"10.1093","volume":"51","author":[{"given":"Takeshi","family":"NONOSHITA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"SHIOYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumasa","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torahiko","family":"NAKASHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiji","family":"OHGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamasa","family":"YOSHITAKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"OHNISHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"TERASHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"ASAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"HONDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"1","unstructured":"1. Howell-Burke D, <i>et al<\/i> (1990) T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg <b>116<\/b>: 830-851."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Inoue T, <i>et al<\/i> (1992) Prognostic factor of telecobalt therapy for early glottic carcinoma. Cancer <b>70<\/b>: 2797-2801.","DOI":"10.1002\/1097-0142(19921215)70:12<2797::AID-CNCR2820701212>3.0.CO;2-5"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00284-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mendenhall WM, <i>et al<\/i> (2001) T1-2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol <b>19<\/b>: 4029-4036.","DOI":"10.1200\/JCO.2001.19.20.4029"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-005-1517-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Akimoto T, <i>et al<\/i> (2006) Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys <b>15<\/b>: <b>64<\/b>: 995-1001.","DOI":"10.1016\/j.ijrobp.2005.10.003"},{"key":"7","unstructured":"7. Niibe Y, <i>et al<\/i> (2007) Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan. Anticancer Res <b>27<\/b>: 3497-3500."},{"key":"8","unstructured":"8. Nishimura G, <i>et al<\/i> (2009) Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation. Anticancer Res <b>29<\/b>: 661-666."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Harada K, <i>et al<\/i> (2005) S-1, an oral fluoropyrimidine anti-cancer agent, enhanced radiosensitivity in a human oral cancer cell line in vivo and in vitro: involvement possibility of inhibition of survival signal, Akt\/PKB. Cancer Lett <b>226<\/b>: 161-168.","DOI":"10.1016\/j.canlet.2004.12.048"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00943.x"},{"key":"11","unstructured":"11. Harada K, Ferdous T and Yoshida H (2007) Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma. Oncol Rep <b>18<\/b>: 1077-1083."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tsukuda M, <i>et al<\/i> (2009) Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and\/or cases with comorbidity. Cancer Chemother Pharmacol <b>64<\/b>: 945-952.","DOI":"10.1007\/s00280-009-0946-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Barton MB, <i>et al<\/i> (1992) The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol <b>23<\/b>: 137-143.","DOI":"10.1016\/0167-8140(92)90323-M"},{"issue":"11","key":"14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0360-3016(81)90078-X","volume":"7","year":"1981","ISSN":"https:\/\/id.crossref.org\/issn\/0360-3016","issn-type":"print"},{"issue":"6","key":"15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0360-3016(91)90230-2","volume":"20","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0360-3016","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mendenhall WM, <i>et al<\/i> (2004) Management of T1-T2 glottic carcinomas. Cancer <b>100<\/b>: 1786-1792.","DOI":"10.1002\/cncr.20181"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Frata P, <i>et al<\/i> (2005) Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys <b>63<\/b>: 1387-1394.","DOI":"10.1016\/j.ijrobp.2005.05.013"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199607000-00010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kim HM, <i>et al<\/i> (2009) Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer. Cancer Chemother Pharmacol <b>63<\/b>: 535-541.","DOI":"10.1007\/s00280-008-0836-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cho SH, <i>et al<\/i> (2008) Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer. Dis Esophagus <b>21<\/b>: 697-703.","DOI":"10.1111\/j.1442-2050.2008.00837.x"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6692031"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tsuji H, <i>et al<\/i> (2006) A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma. Oncology <b>71<\/b>: 369-373.","DOI":"10.1159\/000108385"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jrr\/article-pdf\/51\/4\/481\/3294416\/jrr-51-481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T16:39:37Z","timestamp":1551458377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article-lookup\/doi\/10.1269\/jrr.09134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1269\/jrr.09134","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}